Alexandre Reuben Selected Research

I-antigen

1/2017	The hemochromatosis protein HFE 20 years later: An emerging role in antigen presentation and in the immune system.
6/2015	T lymphocyte-derived TNF and IFN-γ repress HFE expression in cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexandre Reuben Research Topics

Disease

50	Neoplasms (Cancer) 05/2022 - 08/2011
30	Melanoma (Melanoma, Malignant) 01/2021 - 10/2014
9	Neoplasm Metastasis (Metastasis) 05/2022 - 11/2016
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
5	Adenocarcinoma of Lung 05/2022 - 10/2017
4	Lung Neoplasms (Lung Cancer) 01/2021 - 08/2011
3	Disease Progression 01/2018 - 03/2016
2	Pathologic Complete Response 01/2021 - 01/2019
2	Adenocarcinoma 01/2021 - 01/2017
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 03/2016
2	Merkel Cell Carcinoma 11/2020 - 11/2016
2	Uveal melanoma 11/2020 - 01/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2021
1	Hyperplasia 01/2021
1	Inflammation (Inflammations) 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Adenocarcinoma in Situ 01/2021
1	Carcinoma (Carcinomatosis) 11/2020
1	Experimental Melanoma 11/2020
1	Malignant Mesothelioma 10/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Tertiary Lymphoid Structures 01/2020
1	Microsatellite Instability 01/2020
1	Dermatitis 09/2019
1	Keratosis 09/2019
1	Inflammatory Breast Neoplasms 01/2019
1	Carcinogenesis 01/2019
1	Headache (Headaches) 01/2018
1	Chills 01/2018
1	Fever (Fevers) 01/2018
1	Hemochromatosis (Bronze Diabetes) 01/2017
1	Myocarditis (Carditis) 01/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017

Drug/Important Bio-Agent (IBA)

21	Immune Checkpoint InhibitorsIBA 01/2021 - 10/2014
10	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2022 - 10/2017
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
7	AntigensIBA 01/2022 - 08/2011
6	CytokinesIBA 01/2021 - 01/2015
6	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
6	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 12/2014
5	IpilimumabIBA 01/2021 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
3	Interleukin-2 (IL2)IBA 01/2022 - 01/2015
3	dabrafenibIBA 01/2021 - 08/2016
3	NivolumabIBA 01/2021 - 11/2018
3	trametinibIBA 01/2021 - 08/2016
2	AntibodiesIBA 01/2022 - 09/2019
2	Circulating Tumor DNAIBA 11/2021 - 01/2020
2	LigandsIBA 05/2021 - 01/2017
2	Peptides (Polypeptides)IBA 01/2021 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2021 - 09/2019
2	Immunologic Factors (Immunomodulators)IBA 01/2021 - 01/2018
2	B7-H1 AntigenIBA 01/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 08/2020 - 11/2016
2	Biological ProductsIBA 01/2020 - 10/2017
2	aldesleukin (Proleukin)FDA Link 01/2018 - 01/2015
2	I-antigenIBA 01/2017 - 06/2015
1	InterleukinsIBA 01/2022
1	urelumabIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 11/2021
1	Programmed Cell Death 1 ReceptorIBA 05/2021
1	Interferon-gamma (Interferon, gamma)IBA 05/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	hydrogen sulfite (bisulfite)IBA 01/2021
1	Lipocalin-2IBA 01/2021
1	EpitopesIBA 01/2021
1	CarcinogensIBA 01/2021
1	16S Ribosomal RNAIBA 01/2021
1	InterferonsIBA 11/2020
1	flt3 ligand protein (flt3 ligand)IBA 11/2020
1	VaccinesIBA 11/2020
1	Dasatinib (BMS 354825)FDA Link 10/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2020
1	pembrolizumabIBA 01/2020
1	NucleotidesIBA 01/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019
1	IACS-010759IBA 01/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2018
1	Transcription Factors (Transcription Factor)IBA 11/2018
1	VemurafenibIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	SteroidsIBA 01/2017
1	2',2'-difluoro-2'-deoxyuridineIBA 01/2017
1	Gemcitabine FDA Link 01/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	Hemochromatosis ProteinIBA 01/2017
1	IronIBA 01/2017

Therapy/Procedure

32	Therapeutics 05/2022 - 08/2011
22	Immunotherapy 01/2022 - 01/2015
4	Precision Medicine 01/2018 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2021 - 08/2015
2	Radiotherapy 01/2020 - 08/2015
1	Chemoradiotherapy 01/2022
1	Castration 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Neoadjuvant Therapy 01/2019